Boundless Bio, Inc. (BOLD)
(Delayed Data from NSDQ)
$1.18 USD
0.00 (0.00%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $1.17 -0.01 (-0.85%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Boundless Bio, Inc. has a market cap of $26.42M, which represents its share price of $1.18 multiplied by its outstanding shares number of 22.39M. As a small-cap company, BOLD's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BOLD 1.18 0.00(0.00%)
Will BOLD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BOLD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BOLD
Boundless Bio, Inc. (BOLD) Upgraded to Buy: Here's What You Should Know
New Strong Sell Stocks for May 1st
BOLD: What are Zacks experts saying now?
Zacks Private Portfolio Services
January Effect Builds Up Momentum: 5 Small-Cap Stocks to Buy
Boundless Bio, Inc. (BOLD) Loses -19.52% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Down -31.59% in 4 Weeks, Here's Why You Should You Buy the Dip in Boundless Bio, Inc. (BOLD)
Other News for BOLD
Boundless Bio GAAP EPS of -$0.70
Boundless Bio (BOLD) Advances Cancer Therapies with Targeted Focus
Boundless Bio reports Q2 EPS (70c), consensus (65c)
Goldman Sachs Initiates Coverage on Boundless Bio (BOLD) with High Risk Note | BOLD Stock News